Concepedia
Statistics
Publications
13
Citations
586
H-Index
12
Active since
2017
Affiliations
University of California San Diego(Current)
Massachusetts General Hospital
Harvard University
University of Michigan
George Washington University
Schafer Boeder is an author at University of California San Diego specializing in diabetes, medicine, and pharmacology.
Top concepts
DiabetesMedicinePharmacologyImmunologyPharmacotherapyMetabolic Syndrome
Publications per year
2017–2024
COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes
Justin M. Gregory, James C. Slaughter, Sara H. Duffus et al. · Diabetes Care · 2020 · 260 citations · Full text
Effect of a glucagon receptor antibody (REMD‐477) in type 1 diabetes: A randomized controlled trial
Jeremy Pettus, Dominic N. Reeds, Tricia Santos Cavaiola et al. · Diabetes Obesity and Metabolism · 2017 · 62 citations · Full text
Clinical Trial Reg, Metabolic Syndrome, Type 1 +13
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial
Jeremy Pettus, Schafer Boeder, Mark P. Christiansen et al. · Nature Medicine · 2022 · 54 citations · Full text
Type 1, Diabetes Management, Diabetes +3
Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemia
Theodore P. Ciaraldi, Schafer Boeder, Sunder Mudaliar et al. · Diabetes Obesity and Metabolism · 2023 · 37 citations · Full text
Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes
Deborah J. Wexler, Ian H. de Boer, Alokananda Ghosh et al. · JAMA Internal Medicine · 2023 · 31 citations · Full text
1–5 of 13